BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8230399)

  • 1. The disposition of suxibuzone in the horse.
    Delbeke FT; Vynckier L; Debackere M
    J Vet Pharmacol Ther; 1993 Sep; 16(3):283-90. PubMed ID: 8230399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition and tolerance of suxibuzone in horses.
    Jaraiz MV; Rodriguez C; San Andres MD; Gonzalez F; San Andres MI
    Equine Vet J; 1999 Sep; 31(5):411-6. PubMed ID: 10505957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and bioequivalence of two suxibuzone oral dosage forms in horses.
    Jaraiz V; Rodriguez C; San Andres MD; Gonzalez F; San Andres MI
    J Vet Pharmacol Ther; 1999 Aug; 22(4):247-54. PubMed ID: 10499236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of inflammation on the disposition of phenylbutazone in thoroughbred horses.
    Mills PC; Ng JC; Auer DE
    J Vet Pharmacol Ther; 1996 Dec; 19(6):475-81. PubMed ID: 8971677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamics and pharmacokinetics of phenylbutazone in calves.
    Arifah AK; Lees P
    J Vet Pharmacol Ther; 2002 Aug; 25(4):299-309. PubMed ID: 12213119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intramuscular bioavailability of a phenylbutazone preparation in the horse.
    Landuyt J; Delbeke FT; Debackere M
    J Vet Pharmacol Ther; 1993 Dec; 16(4):494-500. PubMed ID: 8126767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
    Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
    Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylbutazone in racing greyhounds: plasma and urinary residues 24 and 48 hours after a single intravenous administration.
    Mills PC; Ng JC; Skelton KV; Seawright AA; Auer DE
    Aust Vet J; 1995 Aug; 72(8):304-8. PubMed ID: 8579562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of phenylbutazone in camels.
    Wasfi IA; Abdel Hadi AH; Zorob O; Osman M al-G ; Boni NS
    Am J Vet Res; 1997 Jun; 58(6):636-40. PubMed ID: 9185972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism, excretion, pharmacokinetics and tissue residues of phenylbutazone in the horse.
    Lees P; Taylor JB; Maitho TE; Millar JD; Higgins AJ
    Cornell Vet; 1987 Apr; 77(2):192-211. PubMed ID: 3568689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of phenylbutazone residues in horse tissues with and without enzyme-hydrolysis by LC-MS/MS.
    Boison JO; Dowling T; Johnson R; Kinar J
    Drug Test Anal; 2016 May; 8(5-6):535-8. PubMed ID: 27443208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylbutazone kinetics and metabolite concentrations in the horse after five days of administration.
    Soma LR; Gallis DE; Davis WL; Cochran TA; Woodward CB
    Am J Vet Res; 1983 Nov; 44(11):2104-9. PubMed ID: 6650958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of age on phenylbutazone pharmacokinetics, metabolism and plasma protein binding in goats.
    Eltom SE; Guard CL; Schwark WS
    J Vet Pharmacol Ther; 1993 Jun; 16(2):141-51. PubMed ID: 8345564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of human drug preparations in the horse. III. Orally administered alclofenac.
    Delbeke FT; Landuyt J; Debackere M
    J Vet Pharmacol Ther; 1994 Oct; 17(5):353-8. PubMed ID: 7853459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic studies on phenylbutazone and oxyphenbutazone in goats.
    Cheng Z; Welsh E; Nolan A; McKellar QA
    Vet Rec; 1997 Jan; 140(2):40-3. PubMed ID: 9123796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylbutazone pharmacokinetics and bioavailability in the dromedary camel (Camelus dromedarius).
    Kadir A; Ali BH; al Hadrami G; Bashir AK; Landoni MF; Lees P
    J Vet Pharmacol Ther; 1997 Feb; 20(1):54-60. PubMed ID: 9049950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of phenylbutazone and its metabolites in the horse.
    Gerring EL; Lees P; Taylor JB
    Equine Vet J; 1981 Jul; 13(3):152-7. PubMed ID: 7297544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic studies of flunixin meglumine and phenylbutazone in plasma, exudate and transudate in sheep.
    Cheng Z; McKeller Q; Nolan A
    J Vet Pharmacol Ther; 1998 Aug; 21(4):315-21. PubMed ID: 9731955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of phenylbutazone and oxyphenbutazone in the donkey.
    Cheng Z; McKellar QA; Nolan A; Lees P
    J Vet Pharmacol Ther; 1996 Apr; 19(2):149-51. PubMed ID: 8735424
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the absorption, excretion, and metabolism of suxibuzone and phenylbutazone in humans.
    Yasuda Y; Shindo T; Mitani N; Ishida N; Oono F; Kageyama T
    J Pharm Sci; 1982 May; 71(5):565-72. PubMed ID: 7097505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.